Surabhi Reddy1, Eva Eliassen1, Gerhard R Krueger2, Bibhuti B Das3
1 HHV-6 Foundation, Santa Barbara, CA, USA 2 Department of Pathology & Laboratory Medicine, The University of Texas-Houston Medical School, Houston, TX, USA 3 Departement of Pediatrics, UTSW Medical Center, Dallas, TX, USA
Correspondence Address:
Bibhuti B Das Department of Pediatrics, UTSW Medical Center, 1935 Medical District Dr, Dallas, TX 75235 USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/apc.APC_54_17
Over the last decade, human herpesvirus 6 (HHV-6) has been implicated in the etiology of pediatric myocarditis and subsequent dilated cardiomyopathy (DCM). This review provides an overview of recent literature investigating the pathophysiological relevance of HHV-6 in inflammatory cardiomyopathy. We examined 11 cases of previously published pediatric myocarditis and/or DCM associated with HHV-6 and also our experience of detection of virus particles in vascular endothelium of HHV-6 positive endomyocardial biopsy tissue by electron microscopy. The exact role of the presence of HHV-6 and its load remains controversial as the virus is also found in the heart of healthy controls. Therefore, the question remains open whether and how cardiac HHV-6 may be of pathogenetic importance. Quantitative polymerase chain reaction or mRNA testing allows differentiation between low-level latent virus found in asymptomatic myocardium and active HHV-6 infection. Although only a small number of pediatric cases have been reported in literature, HHV-6 should be considered as a causative agent of inflammatory cardiomyopathy, especially in children under three who might be experiencing a primary infection. Future studies are needed to establish a threshold for determining active infection in biopsy samples and the role of coinfections other cardiotropic viruses.
[FULL TEXT] [PDF]*
|